NEO NeoGenomics Inc

$8.71

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.

Website: https://www.neogenomics.com

Sector
TRADE & SERVICES
Industry
SERVICES-TESTING LABORATORIES
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1077183
Address
12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS, FL, US
Valuation
Market Cap
$1.23B
P/E Ratio
nan
PEG Ratio
3.02
Price to Book
1.36
Performance
EPS
$-0.62
Dividend Yield
—
Profit Margin
-11.90%
ROE
-8.54%
Technicals
50D MA
$10.44
200D MA
$14.25
52W High
$19.11
52W Low
$8.05
Fundamentals
Shares Outstanding
129M
Target Price
$18.27
Beta
1.41

NEO EPS Estimates vs Actual

● Estimated
● Actual

NEO News & Sentiment

Sep 17, 2025 • Benzinga NEUTRAL
NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026 - NeoGenomics ( NASDAQ:NEO )
NeoGenomics NEO is in Phase 18, the final stage of its Adhishthana Cycle on the weekly charts. After more than 850 days of consolidation, the stock shows little sign of breaking out.
Sep 06, 2025 • Benzinga NEUTRAL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO - NeoGenomics ( NASDAQ:NEO )
NEW YORK, Sept. 06, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ( "NeoGenomics" or the "Company" ) NEO. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Sep 02, 2025 • Benzinga SOMEWHAT-BULLISH
Alibaba To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday - Ameresco ( NYSE:AMRC ) , Affiliated Managers Group ( NYSE:AMG )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Guggenheim raised Inventiva S.A. IVA price target from $9 to $13. Guggenheim analyst Etzer Darout ...
Aug 29, 2025 • Benzinga NEUTRAL
Why Is NeoGenomics Stock Soaring Friday - Natera ( NASDAQ:NTRA )
Court invalidates certain Natera patents, clearing NeoGenomics' RaDaR ST assay for commercialization. William Blair says launch could come in Q4 2025; maintains Market Perform rating. Get Discounted Real-Time Trade Alerts For a Volatile Market ( Labor Day Special )
Aug 29, 2025 • Benzinga SOMEWHAT-BULLISH
Affirm Posts Better-Than-Expected Earnings, Joins Ambarella, IREN, Petco Health and Wellness And Other Big Stocks Moving Higher On Friday - Autodesk ( NASDAQ:ADSK ) , Affirm Holdings ( NASDAQ:AFRM )
U.S. stocks were lower, with the Dow Jones index falling over 100 points on Friday. Shares of Affirm Holdings, Inc. AFRM gained 20.1% to $96.10 after the company reported better-than-expected quarterly EPS and sales. Affirm reported quarterly earnings of 20 cents per share, which beat the Street ...
Aug 26, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership
TEM accelerates its healthcare edge with Paige, Deep 6 AI, and Ambry Genetics acquisitions, expanding data, tech and clinical reach.
Sentiment Snapshot

Average Sentiment Score:

0.113
50 articles with scored sentiment

Overall Sentiment:

Neutral

NEO Reported Earnings

Apr 28, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $-0.01
  • Whisper: —
  • Surprise %: 0.0%
Feb 18, 2025
Dec 31, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.04
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: 39.9%
Nov 05, 2024
Sep 30, 2024 (Pre market)
-0.15 Surprise
  • Reported EPS: $-0.14
  • Estimate: $0.01
  • Whisper: —
  • Surprise %: -1494.0%
Jul 29, 2024
Jun 30, 2024 (Post market)
0.03 Surprise
  • Reported EPS: $0.03
  • Estimate: $-0.00
  • Whisper: —
  • Surprise %: 1404.3%
Apr 30, 2024
Mar 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $-0.02
  • Estimate: $-0.05
  • Whisper: —
  • Surprise %: 60.0%
Feb 20, 2024
Dec 31, 2023 (Post market)
0.05 Surprise
  • Reported EPS: $0.03
  • Estimate: $-0.02
  • Whisper: —
  • Surprise %: 250.0%
Nov 06, 2023
Sep 30, 2023 (Post market)
-0.08 Surprise
  • Reported EPS: $-0.15
  • Estimate: $-0.07
  • Whisper: —
  • Surprise %: -110.4%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $-0.05
  • Estimate: $-0.11
  • Whisper: —
  • Surprise %: 54.5%
May 08, 2023
Mar 31, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.15
  • Whisper: —
  • Surprise %: 40.0%

Financials